Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -166,577 | -53,241 | -129,814 | -14,554 | 2,647 |
| Depreciation Amortization | 54,897 | 15,068 | 10,495 | 6,162 | 5,503 |
| Accounts receivable | -21,626 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -4,029 | 1,277 | 1,064 | 379 | 187 |
| Other Working Capital | 29,765 | 10,062 | 2,342 | 1,955 | -5,562 |
| Other Operating Activity | 139,120 | -322 | 92,348 | 987 | -187 |
| Operating Cash Flow | $31,550 | $-27,156 | $-23,565 | $-5,071 | $2,588 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 147,060 | -151,981 | 167,951 | 203,546 | -307,598 |
| PPE Investments | -41,268 | -95,683 | -90,518 | -34,786 | -8,716 |
| Net Acquisitions | -432,558 | N/A | 2,453 | N/A | N/A |
| Sale Of Investment | 6,876 | 7,487 | -20,822 | N/A | N/A |
| Purchase Sale Intangibles | -873 | N/A | -80,000 | N/A | N/A |
| Other Investing Activity | -873 | 0 | -80,000 | 0 | 0 |
| Investing Cash Flow | $-320,763 | $-240,177 | $-20,936 | $168,760 | $-316,314 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 242,048 | N/A | 250,000 | N/A | N/A |
| Debt Repayment | -721 | -1,353 | -155,571 | -432 | -400 |
| Common Stock Issued | 139,868 | 18,313 | 4,110 | 4,205 | 12,853 |
| Financing Cash Flow | $381,195 | $16,960 | $98,539 | $3,773 | $12,453 |
| Beginning Cash Position | 91,395 | 341,768 | 287,730 | 120,268 | 421,541 |
| End Cash Position | 183,377 | 91,395 | 341,768 | 287,730 | 120,268 |
| Net Cash Flow | $91,982 | $-250,373 | $54,038 | $167,462 | $-301,273 |
| Free Cash Flow | |||||
| Operating Cash Flow | 31,550 | -27,156 | -23,565 | -5,071 | 2,588 |
| Capital Expenditure | -41,268 | -95,683 | -90,518 | -34,786 | -8,716 |
| Free Cash Flow | -9,718 | -122,839 | -114,083 | -39,857 | -6,128 |